BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Colorectal cancer AND ATM, TELO1, 472, ENSG00000149311, TEL1, ATD, ATE, DKFZp781A0353, AT1, Q13315, MGC74674, ATDC, ATC, ATA AND Clinical Outcome
9 results:

  • 1. Whole exome germline sequencing in early-onset prostate cancer patients: Genomic findings and clinical outcomes.
    Siegelmann-Danieli N; Neiman V; Bareket-Samish A; Berger R; Peretz A; Alapi H; Tsur E; Patalon T; Beller D; Rimler G; Chodick G; Shohat M
    Prostate; 2024 Jan; 84(1):39-46. PubMed ID: 37842866
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Association of MicroRNA-652 Expression with Radiation Response of colorectal cancer: A Study from Rectal cancer Patients in a Swedish Trial of Preoperative Radiotherapy.
    Pathak S; Meng WJ; Sriramulu S; Jothimani G; Jangamreddy JR; Banerjee A; Ganesan AT; Adell G; Zhang X; Sun-Zhang A; Zhang H; Sun XF
    Curr Gene Ther; 2023; 23(5):356-367. PubMed ID: 37076469
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Fistula-Associated Anal Adenocarcinoma: A 20-Year Single-Center Experience.
    Harpain F; Dawoud C; Wimmer K; Schlager L; Kirchnawy S; Rizk D; Girgis K; Mittermair E; Oberndorfer F; Wöran K; Riss S; Stift A; Stift J
    Ann Surg Oncol; 2023 Jun; 30(6):3517-3527. PubMed ID: 36757514
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Germline susceptibility variants impact clinical outcome and therapeutic strategies for stage III colorectal cancer.
    Lin PC; Yeh YM; Wu PY; Hsu KF; Chang JY; Shen MR
    Sci Rep; 2019 Mar; 9(1):3931. PubMed ID: 30850667
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. clinical Impact of PI3K/BRAF Mutations in RAS Wild Metastatic colorectal cancer: Meta-analysis Results.
    Mohamed A; Twardy B; AbdAllah N; Akhras A; Ismail H; Zordok M; Schrapp K; Attumi T; Tesfaye A; El-Rayes B
    J Gastrointest Cancer; 2019 Jun; 50(2):269-275. PubMed ID: 29388061
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. MicroRNA-binding site polymorphisms in genes involved in colorectal cancer etiopathogenesis and their impact on disease prognosis.
    Schneiderova M; Naccarati A; Pardini B; Rosa F; Gaetano CD; Jiraskova K; Opattova A; Levy M; Veskrna K; Veskrnova V; Buchler T; Landi S; Vodicka P; Vymetalkova V
    Mutagenesis; 2017 Oct; 32(5):533-542. PubMed ID: 29048575
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Genetic variants of DNA repair-related genes predict efficacy of TAS-102 in patients with refractory metastatic colorectal cancer.
    Suenaga M; Schirripa M; Cao S; Zhang W; Yang D; Murgioni S; Rossini D; Marmorino F; Mennitto A; Ning Y; Okazaki S; Berger MD; Miyamoto Y; Gopez R; Barzi A; Yamaguchi T; Loupakis F; Lenz HJ
    Ann Oncol; 2017 May; 28(5):1015-1022. PubMed ID: 28453695
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Special AT-rich sequence binding protein 1 expression correlates with response to preoperative radiotherapy and clinical outcome in rectal cancer.
    Meng WJ; Pathak S; Ding ZY; Zhang H; Adell G; Holmlund B; Li Y; Zhou ZG; Sun XF
    Cancer Biol Ther; 2015; 16(12):1738-45. PubMed ID: 26528635
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Use of the circular stapler in 1000 consecutive colorectal anastomoses: experience of one surgical team.
    Detry RJ; Kartheuser A; Delriviere L; Saba J; Kestens PJ
    Surgery; 1995 Feb; 117(2):140-5. PubMed ID: 7846617
    [TBL] [Abstract] [Full Text] [Related]  


    of 1.